menu
    • menu

    Company profile for PanTher Therapeutics

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PanTher Therapeutics is on a mission to revolutionize cancer care by applying engineering principles to tackle some of the biggest challenges to successfully treating the deadliest cancers.PanTher Therapeutics is on a mission to revolutionize cancer care by applying engineering principles to tackle some of the biggest challenges to successfully treating the deadliest cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PanTher TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    c/o LabCentral 700 Main Street, Cambridge, MA, 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.panthertx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/panther-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/PanTherTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PanTher Finishes 1st Cohort in Pancreatic Cancer Ph1b Trial Early
    PanTher Finishes 1st Cohort in Pancreatic Cancer Ph1b Trial Early

    10 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250910321848/en/PanTher-Completes-First-Cohort-in-Pancreatic-Cancer-Phase-1b-Trial-Ahead-of-Expectations

    BUSINESSWIRE
    10 Sep 2025
    Share Share
    PanTher Starts Ph 1b Trial for Chemo Patch in Pancreatic Cancer
    PanTher Starts Ph 1b Trial for Chemo Patch in Pancreatic Cancer

    07 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250707465778/en/PanTher-Initiates-Phase-1b-Clinical-Trial-of-Absorbable-Long-Lasting-High-Dose-Chemotherapy-Patch-for-Pancreatic-Cancer

    BUSINESSWIRE
    07 Jul 2025
    Share Share
    PanTher Therapeutics Gets FDA Clearance For PTM-101 Phase 1b Study
    PanTher Therapeutics Gets FDA Clearance For PTM-101 Phase 1b Study

    13 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240813853022/en

    BUSINESSWIRE
    13 Aug 2024
    Share Share
    PanTher Presents Positive Data for PTM-101 in Pancreatic Cancer at AACR
    PanTher Presents Positive Data for PTM-101 in Pancreatic Cancer at AACR

    08 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240408573461/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share
    PanTher Therapeutics Awarded $14.2M from CPRIT
    PanTher Therapeutics Awarded $14.2M from CPRIT

    22 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220821005018/en

    BUSINESSWIRE
    22 Aug 2022
    Share Share
    PanTher Initiates Dosing in Phase 1 Trial of PTM-101 for Pancreatic Cancer
    PanTher Initiates Dosing in Phase 1 Trial of PTM-101 for Pancreatic Cancer

    06 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211006005280/en

    BUSINESSWIRE
    06 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search